n-hydroxysuccinimide s-acetylthioacetate has been researched along with platinum in 1 studies
| Studies (n-hydroxysuccinimide s-acetylthioacetate) | Trials (n-hydroxysuccinimide s-acetylthioacetate) | Recent Studies (post-2010) (n-hydroxysuccinimide s-acetylthioacetate) | Studies (platinum) | Trials (platinum) | Recent Studies (post-2010) (platinum) |
|---|---|---|---|---|---|
| 29 | 0 | 14 | 11,422 | 457 | 6,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, K; Yoshida, H | 1 |
1 other study(ies) available for n-hydroxysuccinimide s-acetylthioacetate and platinum
| Article | Year |
|---|---|
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum-refractory/resistant ovarian cancer.
Topics: Adipose Tissue; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Retrospective Studies | 2023 |